MPM Capital Raises $850m to Fund Cancer Drug Companies

MPM Capital Raises $850m to Fund Cancer Drug Companies

The Oncology Impact Fund 2, run by biotechnology investment firm MPM Capital, has raised a total of $850m, including the $650m obtained from UBS clients. It will invest 80% of its capital into privately held start-ups, and the remainder into public companies,...
Permira leads $150m investment in mParticle

Permira leads $150m investment in mParticle

mParticle, the leading customer data infrastructure company, today announced that it has raised $150 million in Series E funding, led by Permira’s growth fund which backs leading tech-enabled and digital businesses. The existing investor base also participated in the...
Arctos Sports Partners Fund Reaches $2.9bn in Assets

Arctos Sports Partners Fund Reaches $2.9bn in Assets

Sports-focused private equity firm Arctos Sports Partners has $2.9bn in assets in its first fund and has made 14 investments, according to a person familiar with the fund’s details. The updated figure means the Arctos Fund I has more than tripled its assets under...